{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:32:46Z","timestamp":1775543566997,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":21,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001750","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:17:17Z","timestamp":1069384637000},"source":"Crossref","is-referenced-by-count":39,"title":["Gonadotrophin-releasing hormone antagonists for assisted conception"],"prefix":"10.1002","author":[{"given":"H","family":"Al-Inany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Aboulghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,10,23]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD001750-BIB1|cit1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hrmone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserlin","volume":"15","author":"Albano","year":"2000","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD001750-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group","volume":"15","author":"Borm","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750-BIB3|cit3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","year":"2001","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750-BIB4|cit4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001750-BIB5|cit5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorlin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001750-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(00)00414-3","article-title":"A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the \"follicle-stimulating hormone window\" combined with the gonadotropin-releasing hormone antagonist cetrorelix","volume":"73","author":"Jong","year":"2000","journal-title":"Fertility & Sterility"},{"issue":"11","key":"10.1002\/14651858.CD001750-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","article-title":"A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The Ganirelix Dose-finding Study Group","volume":"13","author":"Devroey","year":"1998","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1002\/14651858.CD001750-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/humrep\/13.9.2392","article-title":"Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers","volume":"13","author":"Duijkers","year":"1998","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1002\/14651858.CD001750-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1093\/humrep\/14.9.2242","article-title":"High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles","volume":"14","author":"Kol","year":"1999","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD001750-BIB10|cit10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/humrep\/14.4.885","article-title":"Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?","volume":"14","author":"Lin","year":"1999","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD001750-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/oxfordjournals.humrep.a019058","article-title":"Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)","volume":"11","author":"Albano","year":"1996","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD001750-BIB12|cit12","article-title":"Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles","author":"Daya","year":"1998","journal-title":"The Cochrane Library"},{"issue":"5","key":"10.1002\/14651858.CD001750-BIB13|cit13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous lutenizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD001750-BIB14|cit14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0301-2115(95)02138-W","article-title":"Preserved pituitary response under ovarian stimulation with hMG and GnRH-antagonists (Cetrorelix) in women with tubal infertility","volume":"61","author":"Felberbaum","year":"1995","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"6","key":"10.1002\/14651858.CD001750-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/15.6.1211","article-title":"Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonist","volume":"15","author":"Hernandez","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750-BIB16|cit16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"9","key":"10.1002\/14651858.CD001750-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/humrep\/15.9.1882","article-title":"Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor","volume":"15","author":"Mannaerts","year":"2000","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD001750-BIB18|cit18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in an in-vitro fertilisation- embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertility & Sterility"},{"issue":"9","key":"10.1002\/14651858.CD001750-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/13.9.2411","article-title":"The use of GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2mg","volume":"13","author":"Olivennes","year":"1998","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD001750-BIB20|cit20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/humrep\/16.4.608","article-title":"Embryo implantation and GnRH antagonists: Ovarian actions of GnRH antagonists","volume":"16","author":"Ortmann","year":"2001","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD001750-BIB21|cit21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/14.3.683","article-title":"Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation","volume":"14","author":"Rongieres-Bertrand","year":"1999","journal-title":"Human Reproduction"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:05:02Z","timestamp":1628543102000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001750"}},"subtitle":[],"editor":[{"given":"Hesham","family":"Al-Inany","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,10,23]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001750","relation":{},"subject":[],"published":{"date-parts":[[2001,10,23]]}}}